These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16520381)

  • 1. alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function.
    Shiau CW; Huang JW; Wang DS; Weng JR; Yang CC; Lin CH; Li C; Chen CS
    J Biol Chem; 2006 Apr; 281(17):11819-25. PubMed ID: 16520381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
    Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
    Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
    Swettenham E; Witting PK; Salvatore BA; Neuzil J
    J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y; Tang W; Dai Y; Wu X; Liu M; Ji Q; Ji M; Pienta K; Lawrence T; Xu L
    Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
    Reagan-Shaw S; Nihal M; Ahsan H; Mukhtar H; Ahmad N
    Prostate; 2008 Nov; 68(15):1624-34. PubMed ID: 18668529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells.
    Zu K; Hawthorn L; Ip C
    Mol Cancer Ther; 2005 Jan; 4(1):43-50. PubMed ID: 15657352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J; Wu Y; Yang D; Zhao Y
    Oncol Rep; 2013 Aug; 30(2):731-8. PubMed ID: 23708869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression.
    Liu QY; Stein CA
    Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention.
    Wu Y; Zu K; Ni J; Yeh S; Kasi D; James NS; Chemler S; Ip C
    Anticancer Res; 2004; 24(6):3795-802. PubMed ID: 15736414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression.
    Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B
    Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
    Yu W; Sanders BG; Kline K
    Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
    Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS
    J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.
    Castilla C; Congregado B; Chinchón D; Torrubia FJ; Japón MA; Sáez C
    Endocrinology; 2006 Oct; 147(10):4960-7. PubMed ID: 16794010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.